HTA Details
Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding
- Publication date
-
2016-November-01
- Status
- Final
- Topic Area
- Gynecological
- Recommendation
-
Ontario Health Technology Advisory Committee Recommendation
- The Ontario Health Technology Advisory Committee recommends publicly funding the 52-mg levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding
- Ministry Response
-
The Ministry of Health and Long-Term Care has accepted this recommendation.
-
To read the full OHTAC Recommendation Report for this topic, contact our Health Innovation team using the contact form to request a digital copy.
Heavy menstrual bleeding can be painful, distressing and disruptive. Up to one-third of women between the ages of 15 and 55 experience heavy menstrual bleeding, and often the cause is unknown. However, treatment can reduce the symptoms and improve quality of life. Some options include medications, surgery, and a device called the levonorgestrel-releasing intrauterine system.
The levonorgestrel-releasing intrauterine system is a minimally invasive and reversible device that is inserted in the uterus where it releases a hormone that suppresses and thins the lining of the uterus (endometrium), which can result in a reduction in the amount of bleeding. Currently, the insertion procedure is publicly funded in Ontario but the cost of the device is not.
Last Updated: February 24, 2026
